Molecular Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Chemical and Biological Aspects of Inflammation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takai, N.
Right arrow Articles by Koeffler, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takai, N.
Right arrow Articles by Koeffler, H. P.
Molecular Cancer Research 3:261-269 (2005)
© 2005 American Association for Cancer Research


Cancer Genes and Genomics

Discovery of Epigenetically Masked Tumor Suppressor Genes in Endometrial Cancer

Noriyuki Takai1,5, Norihiko Kawamata1, Christine S. Walsh1,2, Sigal Gery1, Julian C. Desmond1, Sadie Whittaker1, Jonathan W. Said3, Laura M. Popoviciu3, Peter A. Jones4, Isao Miyakawa5 and H. Phillip Koeffler1

1 Division of Hematology/Oncology and 2 Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center and 3 Department of Pathology, Center of Health Science, University of California at Los Angeles School of Medicine; 4 Department of Biochemistry, School of Medicine, University of Southern California, Los Angeles, CA and 5 Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Oita, Japan

Requests for reprints: Norihiko Kawamata, Division of Hematology/Oncology, Cedars-Sinai Medical Center/University of California at Los Angeles School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA 90048. Phone: 310-423-7736; Fax: 310-423-0443. E-mail: kawamatan{at}cshs.org

Realization that many tumor suppressor genes are silenced by epigenetic mechanisms has stimulated the discovery of novel tumor suppressor genes. We used a variety of research tools to search for genes that are epigenetically silenced in human endometrial cancers. Changes in global gene expression of the endometrial cancer cell line Ishikawa was analyzed after treatment with the demethylating agent 5-aza-2'-deoxycytidine combined with the histone deacetylase inhibitor suberoylanilide bishydroxamide. By screening over 22,000 genes, candidate tumor suppressor genes were identified. Additional microarray analysis and real-time reverse transcription-PCR of normal and cancerous endometrial samples and search for CpG islands further refined the list. Tazarotene-induced gene-1 (Tig1) and CCAAT/enhancer binding protein-{alpha} (C/ebp{alpha}) were chosen for further study. Expression of both genes was low in endometrial cancer cell lines and clinical samples but high in normal endometrial tissues. Bisulfite sequencing, restriction analysis, and/or methylation-specific PCR revealed aberrant methylation of the CpG island in the Tig1 gene of all 6 endometrial cancer cell lines examined and 4 of 18 clinical endometrial cancers, whereas the C/ebp{alpha} promoter remained unmethylated in endometrial cancers. Chromatin immunoprecipitation showed increased acetylated histone H3 bound to both Tig1 and C/ebp{alpha} genes after treatment with 5-aza-2'-deoxycytidine and/or suberoylanilide bishydroxamide. Forced expression of either TIG1 or C/EBP{alpha} led to significant growth reduction of Ishikawa cells. Our data suggest that C/ebp{alpha} and Tig1 function as tumor suppressor proteins in endometrial cancers and that their reexpression may be a therapeutic target.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K. D. Loomis, S. Zhu, K. Yoon, P. F. Johnson, and R. C. Smart
Genetic Ablation of CCAAT/Enhancer Binding Protein {alpha} in Epidermis Reveals Its Role in Suppression of Epithelial Tumorigenesis
Cancer Res., July 15, 2007; 67(14): 6768 - 6776.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
R. Vibhakar, G. Foltz, J.-g. Yoon, L. Field, H. Lee, G.-y. Ryu, J. Pierson, B. Davidson, and A. Madan
Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma
Neuro-oncol, April 1, 2007; 9(2): 135 - 144.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. L. Hecht and G. L. Mutter
Molecular and Pathologic Aspects of Endometrial Carcinogenesis
J. Clin. Oncol., October 10, 2006; 24(29): 4783 - 4791.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Foltz, G.-Y. Ryu, J.-G. Yoon, T. Nelson, J. Fahey, A. Frakes, H. Lee, L. Field, K. Zander, Z. Sibenaller, et al.
Genome-Wide Analysis of Epigenetic Silencing Identifies BEX1 and BEX2 as Candidate Tumor Suppressor Genes in Malignant Glioma.
Cancer Res., July 1, 2006; 66(13): 6665 - 6674.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. S. Basseres, E. Levantini, H. Ji, S. Monti, S. Elf, T. Dayaram, M. Fenyus, O. Kocher, T. Golub, K.-k. Wong, et al.
Respiratory Failure Due to Differentiation Arrest and Expansion of Alveolar Cells following Lung-Specific Loss of the Transcription Factor C/EBP{alpha} in Mice
Mol. Cell. Biol., February 1, 2006; 26(3): 1109 - 1123.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.